This is a limited company view. Sign up for a Free Trial to see everything.

CT Atlantic AG is a Swiss biotech company researches and develops novel, human-derived antibodies for the treatment of cancer.

Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Zurich

Founded

Employees

0

Stage

Series A

Total funding

$9M

Last funding

9 years ago

Acquisitions

0

Growth score

-56

Mindshare score

-56

Scoring

Deals

$9.0M Series A

QureInvest

Jan 12, 2009

Employee Growth

Use CT Atlantic's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use CT Atlantic's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes